期刊文献+

不同剂量阿托伐他汀在脑梗死患者治疗中的应用探讨 被引量:1

Discussion on the Application of Different Doses of Atorvastatin in Treatment of Patients with Cerebral Infarction
下载PDF
导出
摘要 目的探讨不同剂量阿托伐他汀在治疗脑梗死患者中临床疗效。方法随机选取我院近年来收治的120例脑梗死患者,随机分为A、B、C三组,每组40例,A组:采取常规治疗。 B、C组:在A组治疗的基础上,分别服用阿托伐他汀10mg/d、20mg/d治疗。2w后观察每组血脂、血清hs-CRP及神经功能的改善程度。结果治疗后,B、C组在改善血脂水平及血清hs-CRP方面均显著优于A组,且C组效果更好;C组的NIHSS评分也显著低于B组,差异具有统计学意义(<0.05)。结论阿托伐他汀在治疗急性脑梗时,具有较好的临床疗效,且20mg治疗效果更佳。 Objective To investigate the effects of dif erent doses of atorvastatin in the treatment of cerebral infarction in patients with clinical ef icacy.Methods In our hospital in recent years treated 120 cases with cerebral infarction were randomly divided into A,B,C3 group,40 cases in each group,group A:take the conventional treatment.B,C group:A group based on the treatment of atorvastatin,respectively 10mg/d,20mg/d treatment.Degree of improvement were observed after 2 weeks of blood lipid,serum hs-CRP and neural function.Results After the treatment,B,C group in improvement of blood lipid level and serum hs-CRP were significantly better than those in A group,and C group was best;group C NIHSS score was significantly lower than that of B group(P<0.05).Conclusion Atorvastatin in the treatment of acute cerebral infarction,the clinical ef icacy is good,and bet er therapeutic ef ect of 20mg.
作者 彭亚利 PENG Ya-li(Department of Neurology,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
出处 《医学信息(医学与计算机应用)》 2014年第25期88-88,共1页 Medical Information
关键词 不同剂量 阿托伐他汀 脑梗死 应用探讨 Different dose Atorvastatin Cerebral infarction Application
  • 相关文献

参考文献5

二级参考文献42

  • 1他汀类药物预防缺血性卒中/短暂性脑缺血发作的专家建议[J].中华内科杂志,2007,46(1):81-83. 被引量:124
  • 2任天舒,李林鹏,姜远英.高胆固醇血症大鼠自由基代谢紊乱及阿托伐他汀的干预作用[J].药学实践杂志,2007,25(3):143-144. 被引量:15
  • 3Vaughan C J,Delanty N,Basson CT. Do statins afford neuroprotection in patients with cerebral ischaemia and stroke? CNS Drugs 2001; 15:589 - 96.
  • 4Vaughan C J,Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 1999; 30:1969 -73.
  • 5Sawada N,Itoh H,Nakao K. Novel actions of HMG-CoA reductase inhibitors(statins) -vascular and cerebral protection through inhibition of small GTPase Rho. Nippon Rinsho 2001;59:2470-5.
  • 6Delanty N,Vaughan C J,Sheehy N. Statins and neuroprotection. Expert Opin Investig Drugs 2001; 10:1847-53.
  • 7Vaughan CJ. Prevention of stroke and dementia with statins: Effects beyond lipid lowering. Am J Cardiol 2003; 91: 23B - 29B.
  • 8Karaca I,Ilkay E,Akbulut M,et al. Atorvastatin affects C-reactive protein levels in patients with coronary artery disease. Curr Med Res Opin 2003; 19:187 - 91.
  • 9Lee KT,Lai WT,Chu CS,et al. Effect of withdrawal of statin on C-reactive protein. Cardiology 2004; 102:166 -70.
  • 10Ercan E,Tengiz I,Altuglu I,et al. Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia. Kardiol Pol 2004;60:454 - 8.

共引文献110

同被引文献14

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部